Form 4 for SNA Snap-on
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000091440-26-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-17 | 2026-02-12 | SNA | Miller Richard Thomas | VP, Gen Counsel, Sec | F - Tax | $378.55 | -204 | 4,952 | -4% | -$77.2K |
| D | 2026-02-17 | 2026-02-12 | SNA | Miller Richard Thomas | VP, Gen Counsel, Sec | M - OptEx | — | +631 | 5,156 | +14% | — |
| DM | 2026-02-17 | 2026-02-12 | SNA | Miller Richard Thomas | VP, Gen Counsel, Sec | A - Grant | $0.00 | +3,634 | 508 | New | $0 |
| DM | 2026-02-17 | 2026-02-12 | SNA | Miller Richard Thomas | VP, Gen Counsel, Sec | M - OptEx | — | -631 | 0 | -100% | — |
| D | 2026-02-17 | 2026-02-12 | SNA | Miller Richard Thomas | VP, Gen Counsel, Sec | D - Sale to Iss | — | -337 | 774 | -30% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-12 | F | D | 204 | $378.55 | 4,951.89 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-12 | M | A | 631 | — | 5,155.89 | D | — | — | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. |
| 3 | Derivative | Performance Units | 2026-02-12 | A | A | 1,016 | $0.00 | 1,016 | D | — · — to — | 1,016 Common Stock | (F3) 1 for 1. (F9) If the Company achieves certain goals over the 2026-2028 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. |
| 4 | Derivative | Deferred Stock Units | 2026-02-12 | M | A | 143 | — | 1,168.37 | D | — · — to — | 143 Common Stock | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F5) This information is based on a plan statement dated December 31, 2025, as updated by the transaction being reported on this Form 4 and the transaction reported on the Form 4 dated February 9, 2026. (F3) 1 for 1. (F4) Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-02-12 | A | A | 2,110 | $0.00 | 2,110 | D | $378.55 · 2027-02-12 to 2036-02-12 | 2,110 Common Stock | (F7) The transaction was an option grant. Accordingly, the reporting person did not pay a price to obtain the option. (F6) Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. |
| 6 | Derivative | Restricted Stock Units | 2026-02-12 | A | A | 508 | $0.00 | 508 | D | — · 2029-02-12 to 2029-02-12 | 508 Common Stock | (F3) 1 for 1. (F8) The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. |
| 7 | Derivative | Performance Units | 2026-02-12 | M | D | 631 | — | 143 | D | — · — to — | 631 Common Stock | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F3) 1 for 1. |
| 8 | Derivative | Performance Units | 2026-02-12 | D | D | 337 | — | 774 | D | — · — to — | 337 Common Stock | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F3) 1 for 1. |
| 9 | Derivative | Performance Units | 2026-02-12 | M | D | 143 | — | 0 | D | — · — to — | 143 Common Stock | (F1) Based on Company performance during the 2023-2025 period, 69.7% of the performance units vested (as previously disclosed, the reporting person had the opportunity to earn up to 200% of the number originally reported, subject to plan limits). The reporting person elected to defer the receipt of a portion of the underlying shares. (F3) 1 for 1. |